palmidrol has been researched along with Diabetes Mellitus, Type 2 in 4 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The observed alterations emphasize, for the first time in humans, the potential different role and regulation of adipose tissue anandamide (and its congeners) and 2-AG in obesity and type 2 diabetes." | 3.76 | Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. ( Annuzzi, G; Bozzetto, L; Costabile, G; Di Marino, L; Di Marzo, V; Giacco, R; Patti, L; Petrosino, S; Piscitelli, F; Riccardi, G; Rivellese, AA; Verde, R, 2010) |
| "The management of the associated neuropathic pain remains difficult to treat." | 3.11 | A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. ( Pickering, E; Rao, A; Steadman, KJ; Steels, EL; Vitetta, L, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pickering, E | 1 |
| Steels, EL | 1 |
| Steadman, KJ | 1 |
| Rao, A | 1 |
| Vitetta, L | 1 |
| Semprini, R | 1 |
| Martorana, A | 1 |
| Ragonese, M | 1 |
| Motta, C | 1 |
| Annuzzi, G | 1 |
| Piscitelli, F | 1 |
| Di Marino, L | 1 |
| Patti, L | 1 |
| Giacco, R | 1 |
| Costabile, G | 1 |
| Bozzetto, L | 1 |
| Riccardi, G | 1 |
| Verde, R | 1 |
| Petrosino, S | 2 |
| Rivellese, AA | 1 |
| Di Marzo, V | 2 |
| Matias, I | 1 |
| Gonthier, MP | 1 |
| Docimo, L | 1 |
| Capasso, R | 1 |
| Hoareau, L | 1 |
| Monteleone, P | 1 |
| Roche, R | 1 |
| Izzo, AA | 1 |
1 trial available for palmidrol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.
Topics: Australia; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Inflammation; Neuralgia; Treatm | 2022 |
3 other studies available for palmidrol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Observational clinical and nerve conduction study on effects of a nutraceutical combination on painful diabetic distal symmetric sensory-motor neuropathy in patients with diabetes type 1 and type 2.
Topics: Abietanes; Adult; Amides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathie | 2018 |
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.
Topics: Adiposity; Adult; Amides; Arachidonic Acids; Cannabinoid Receptor Modulators; Diabetes Mellitus, Typ | 2010 |
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells.
Topics: 3T3 Cells; Adipocytes; Adult; Aged; Amides; Animals; Arachidonic Acids; Diabetes Mellitus, Type 2; E | 2007 |